ASCL1 is a bHLH transcription factor that acts as a pioneer factor in neuronal differentiation, directly binding E-box motifs to activate neural gene transcription 1. Its primary functions include specification of olfactory, autonomic, and pulmonary neuroendocrine cells, as well as GABAergic neuron generation when combined with other factors like DLX2 2. ASCL1 regulates distinct oncogenic programs including MYCL1, RET, SOX2, NFIB, and NOTCH pathway genes, distinguishing it from the related factor NEUROD1 1. In disease contexts, ASCL1 defines a molecular subtype of small cell lung cancer (SCLC-A) characterized by high neuroendocrine marker expression and associated with poor prognosis 34. ASCL1 is essential for SCLC tumor formation in mouse models and drives neuroendocrine differentiation in prostate cancer through lineage plasticity 15. Notably, ASCL1 expression shows dynamic evolution under MYC-driven selection, shifting between SCLC subtypes 6. Epigenetic regulators like KDM6A control ASCL1-to-NEUROD1 subtype plasticity, explaining the 35-40% of human SCLCs displaying intra-tumoral subtype heterogeneity 7. Clinically, ASCL1+ SCLC tumors with high SLFN11 expression correlate with poor survival, while spatial immune analysis identifies antitumoral niches predicting immunotherapy response 4. In asthma, ASCL1-dependent pulmonary neuroendocrine cells amplify allergic responses through CGRP-ILC2 signaling 8.